Prevention and treatment of urinary catheter-associated infections

Current Infectious Disease Reports

Volumn 15, Issue 2, 2013, Pages 116-123

  Al Mohajer, Mayar ^a   Darouiche, Rabih O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bacteriuria; Catheter; Prevention; Treatment; Urinary tract infection

Indexed keywords

ANTIINFECTIVE AGENT; CEFALEXIN; CEPHALOSPORIN; CIPROFLOXACIN; GLYCOPEPTIDE; LATEX; LEVOFLOXACIN; NITROFURAL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SILICON; SILVER;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BIOFILM; BLADDER CATHETERIZATION; CATHETER INFECTION; DEVICE INFECTION; DIAGNOSTIC TEST; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; HYDROGEL; INFECTION CONTROL; INFECTION RISK; NONHUMAN; PATHOGENESIS; URINARY CATHETER; URINARY TRACT INFECTION; URINE CULTURE;

EID: 84877923536     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-013-0316-6     Document Type: Article

References (71)

1. Weinstein RA. Health-care associated infections. In: Kasper DL, Fauci AS, editors. Harrison's infectious diseases. China: McGraw-Hill Companies Inc; 2010. p. 144-53.
2. Siddiq DM, Darouiche RO. New strategies to prevent catheter-associated urinary tract infections. Nat Rev Urol. 2012;9(6):305-14. This article provides important information on the prevention of CA-UTI.
3. Smith PW, Bennett G, Bradley S, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infect Control Hosp Epidemiol. 2008;29(9):785-814.
4. Hooton TM. Nosocomial Urinary Tract Infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases, vol. 2. 7th ed. Philadelphia: Elsevier Inc; 2010. p. 3725-37.
5. Haley RW, Hooton TM, Culver DH, et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med. 1981;70(4):947-59.
6. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625-63. These guidelines provide very important information on prevention and management of CA-UTI.
7. Nicolle LE. Urinary catheter-associated infections. Infect Dis Clin North Am. 2012;26(1):13-27.
8. Nicolle LE. Catheter-related urinary tract infection. Drugs Aging. 2005;22(8):627-39.
9. Warren JW, Tenney JH, Hoopes JM, et al. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982;146(6):719-23.
10. Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am. 2003;17(2):411-32.
11. Jacobsen SM, Stickler DJ, Mobley HL, et al. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 2008;21(1):26-59.
12. Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis. 2001;7(2):342-7.
13. Garibaldi RA, Burke JP, Dickman ML, et al. Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med. 1974;291(5):215-9.
14. Garibaldi RA, Burke JP, Britt MR, et al. Meatal colonization and catheter-associated bacteriuria. N Engl J Med. 1980;303(6):316-8.
15. Platt R, Polk BF, Murdock B, et al. Risk factors for nosocomial urinary tract infection. Am J Epidemiol. 1986;124(6):977-85.
16. Bakke A, Digranes A, Høisaeter PA. Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. Br J Urol. 1997;79(1):85-90.
17. Bakke A, Vollset SE. Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. J Urol. 1993;149(3):527-31.
18. Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000;160(5):678-82.
19. Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40(5):643-54.
20. Griffiths R, Fernandez R. Strategies for the removal of short-term indwelling urethral catheters in adults. Cochrane Database Syst Rev. 2007;2:CD004011.
21. Phipps S, Lim YN, McClinton S, et al. Short term urinary catheter policies following urogenital surgery in adults. Cochrane Database Syst Rev. 2006;2:CD004374.
22. Gokula RR, Hickner JA, Smith MA. Inappropriate use of urinary catheters in elderly patients at a midwestern community teaching hospital. Am J Infect Control. 2004;32(4):196-9.
23. Garibaldi RA, Mooney BR, Epstein BJ, et al. An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection. Infect Control. 1982;3(6):466-70.
24. Goetz AM, Kedzuf S, Wagener M, et al. Feedback to nursing staff as an intervention to reduce catheter-associated urinary tract infections. Am J Infect Control. 1999;27(5):402-4.
25. Rosenthal VD, Guzman S, Safdar N. Effect of education and performance feedback on rates of catheter-associated urinary tract infection in intensive care units in Argentina. Infect Control Hosp Epidemiol. 2004;25(1):47-50.
26. Apisarnthanarak A, Thongphubeth K, Sirinvaravong S, et al. Effectiveness of multifaceted hospitalwide quality improvement programs featuring an intervention to remove unnecessary urinary catheters at a tertiary care center in Thailand. Infect Control Hosp Epidemiol. 2007;28(7):791-8.
27. Bruminhent J, Keegan M, Lakhani A, et al. Effectiveness of a simple intervention for prevention of catheter-associated urinary tract infections in a community teaching hospital. Am J Infect Control. 2010;38(9):689-93. This article provides important information on the use of reminder stickers in preventing CA-UTI.
28. Blodgett TJ. Reminder systems to reduce the duration of indwelling urinary catheters: a narrative review. Urol Nurs. 2009;29(5):369-78. quiz 379.
29. Meddings J, Rogers MA, Macy M, et al. Systematic review and meta-analysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis. 2010;51(5):550-60.
30. Saint S, Kaufman SR, Rogers MA, et al. Condom versus indwelling urinary catheters: a randomized trial. J Am Geriatr Soc. 2006;54(7):1055-61.
31. Niël-Weise BS, van den Broek PJ. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev. 2005;3:CD004203.
32. Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc. 1999;74(2):131-6.
33. Carapeti EA, Andrews SM, Bentley PG. Randomised study of sterile versus non-sterile urethral catheterisation. Ann R Coll Surg Engl. 1996;78(1):59-60.
34. Lo E, Nicolle L, Classen D, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S41-50.
35. Kass EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Phys. 1956;69:56-64.
36. Kunin CM, McCormack RC. Prevention of catheter-induced urinary-tract infections by sterile closed drainage. N Engl J Med. 1966;274(21):1155-61.
37. Rutala WA, Kennedy VA, Loflin HB, et al. Serratia marcescens nosocomial infections of the urinary tract associated with urine measuring containers and urinometers. Am J Med. 1981;70(3):659-63.
38. Crnich CJ, Drinka PJ. Does the composition of urinary catheters influence clinical outcomes and the results of research studies? Infect Control Hosp Epidemiol. 2007;28(1):102-3.
39. Srinivasan A, Karchmer T, Richards A, et al. A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol. 2006;27(1):38-43.
40. Stensballe J, Tvede M, Looms D, et al. Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Ann Intern Med. 2007;147(5):285-93.
41. Schumm K, Lam TB. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev. 2008;2:CD004013.
42. Pickard R, Lam T, Maclennan G, et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 2012 Nov 2.
43. Seymour C. Audit of catheter-associated UTI using silver alloy-coated Foley catheters. Br J Nurs. 2006;15(11):598-603.
44. Rupp ME, Fitzgerald T, Marion N, et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control. 2004;32(8):445-50.
45. Lee SJ, Kim SW, Cho YH, et al. A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters. Int J Antimicrob Agents. 2004;24 Suppl 1:S65-9.
46. Al-Habdan I, Sadat-Ali M, Corea JR, et al. Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. Int Surg. 2003;88(3):152-4.
47. Lai KK, Fontecchio SA. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control. 2002;30(4):221-5.
48. Newton T, Still JM, Law E. A comparison of the effect of early insertion of standard latex and silver-impregnated latex foley catheters on urinary tract infections in burn patients. Infect Control Hosp Epidemiol. 2002;23(4):217-8.
49. Karchmer TB, Giannetta ET, Muto CA, et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med. 2000;160(21):3294-8.
50. Thibon P, Le Coutour X, Leroyer R, et al. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J Hosp Infect. 2000;45(2):117-24.
51. Bologna RA, Tu LM, Polansky M, et al. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology. 1999;54(6):982-7.
52. Verleyen P, De Ridder D, Van Poppel H, et al. Clinical application of the Bardex IC Foley catheter. Eur Urol. 1999;36(3):240-6.
53. Liedberg H, Lundeberg T, Ekman P. Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria. An experimental and clinical study. Eur Urol. 1990;17(3):236-40.
54. Liedberg H, Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br J Urol. 1990;65(4):379-81.
55. Saint S, Lipsky BA. Preventing catheter-related bacteriuria: should we? Can we? How? Arch Intern Med. 1999;159(8):800-8.
56. Petronella P, Scorzelli M, Fiore A, et al. Antibiotic prophylaxis in catheter-associated urinary infections. New Microbiol. 2012;35(2):191-8.
57. Rutschmann OT, Zwahlen A, et al. Use of norfloxacin for prevention of symptomatic urinary tract infection in chronically catheterized patients. Eur J Clin Microbiol Infect Dis. 1995;14(5):441-4.
58. Gribble MJ, Puterman ML. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med. 1993;95(2):141-52.
59. Darouiche RO, Hull RA. Bacterial interference for prevention of urinary tract infection. Clin Infect Dis. 2012;55(10):1400-7. This article provides very important information on the use of bacterial interference for preventing catheter-related urinary tract infections.
60. Hull RA, Rudy DC, Donovan WH, et al. Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun. 1999;67(1):429-32.
61. Darouiche RO, Green BG, Donovan WH, et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology. 2011;78(2):341-6.
62. Sobel JD, Kauffman CA, McKinsey D, et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis. 2000;30(1):19-24.
63. Trautner BW. Management of catheter-associated urinary tract infection. Curr Opin Infect Dis. 2010;23(1):76-82. This article provide important information on the management of CA-UTI and medicare rule changes in the USA.
64. Leone M, Perrin AS, Granier I, et al. A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients. Intensive Care Med. 2007;33(4):726-9.
65. Warren JW, Anthony WC, Hoopes JM, et al. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA. 1982;248(4):454-8.
66. Maynard FM, Diokno AC. Urinary infection and complications during clean intermittent catheterization following spinal cord injury. J Urol. 1984;132(5):943-6.
67. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329(18):1328-34.
68. Bergqvist D, Brönnestam R, Hedelin H, et al. The relevance of urinary sampling methods in patients with indwelling Foley catheters. Br J Urol. 1980;52(2):92-5.
69. Tenney JH, Warren JW. Bacteriuria in women with long-term catheters: paired comparison of indwelling and replacement catheters. J Infect Dis. 1988;157(1):199-202.
70. Raz R, Schiller D, Nicolle LE. Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol. 2000;164(4):1254-8.
71. Peterson J, Kaul S, Khashab M, et al. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology. 2008;71(1):17-22.